Search PDMR transactions

Notifier
Name of person with notification obligation
Anders Bladh
Reason for notification
Closely associated
Yes
Person discharging managerial responsibilities
Anders Bladh
Position
Member of the Board of Directors
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
XSpray Pharma AB (publ)
Issuer´s LEI code
549300NGRQCNZ3X4L157
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share XSpray Pharma AB SE0009973563 Exercise increase 300,000 Quantity 40.00 SEK 30/11/2023 NASDAQ STOCKHOLM AB
Subcription warrant Xspray Pharma AB TO5 SE0020353548 Exercise decrease 300,000 Quantity 0.00 SEK 30/11/2023 NASDAQ STOCKHOLM AB
Share XSpray Pharma AB SE0009973563 Exercise increase 1,628 Quantity 40.00 SEK 30/11/2023 NASDAQ STOCKHOLM AB
Subcription warrant Xspray Pharma AB TO5 SE0020353548 Exercise decrease 1,628 Quantity 0.00 SEK 30/11/2023 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
XSpray Pharma AB SE0009973563 Exercise increase 30/11/2023 NASDAQ STOCKHOLM AB 301,628 (Quantity) 40.00 SEK
Xspray Pharma AB TO5 SE0020353548 Exercise decrease 30/11/2023 NASDAQ STOCKHOLM AB 301,628 (Quantity) 0.00 SEK
<< Back